Lindsay M. Burt,
MD
Languages Spoken: English
Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.
Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.
Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.
Clinical Locations
801-213-6355
Fax: (801) 213-6359
801-581-2396
Fax: (801) 585-2666
Specialties
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Assistant Professor (Clinical) |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
August 06, 2021
HUNTSMAN CANCER CENTER
Planned and got excellent results
UofU Patient
June 18, 2021
HUNTSMAN CANCER CENTER
very happy with Dr. Burt and nurse. Dr Burt very caring and helps ease any anxiety or stress. explains everything well and takes time to answer any questions I may have
UofU Patient
June 14, 2021
SUGAR HOUSE HEALTH CENTER
Great staff. Showed a lot of concern and answered all our questions. Made us all feelrelaxed and comfortable.
UofU Patient
May 09, 2021
HUNTSMAN CANCER CENTER
Dr. Burt is very straight forward and I like her approach.
UofU Patient
May 02, 2021
HUNTSMAN CANCER CENTER
The 2 doctors we talked with were both caring and professional.
UofU Patient
April 23, 2021
HUNTSMAN CANCER CENTER
dr Lindsay Burt was excellent
UofU Patient
December 14, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
December 02, 2020
HUNTSMAN CANCER CENTER
Very good
UofU Patient
November 14, 2020
HUNTSMAN CANCER CENTER
I struggled with with the initial treatment plan and then was told it changed. More discussion would have been appreciated. That's a difficult decision for a patient.
UofU Patient
November 02, 2020
HUNTSMAN CANCER CENTER
dr. Burt explain my I options for radiation treatment, very well. She did not rush me at all and was very eager to answer any questions.
UofU Patient
September 22, 2020
SUGAR HOUSE HEALTH CENTER
Dr. Burt was very personable and interested in developing a relationship with me. Her explanation of my diagnosis and procedure were detailed and easy to understand. She spent time making sure all of my questions were answered. I really appreciated the time she spent with me.
UofU Patient
September 05, 2020
HUNTSMAN CANCER CENTER
Very helpful!
UofU Patient
July 31, 2020
HUNTSMAN CANCER CENTER
good experience
UofU Patient
June 24, 2020
HUNTSMAN CANCER CENTER
everyone had been so kind
UofU Patient
June 19, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
May 25, 2020
SUGAR HOUSE HEALTH CENTER
Dr Burt is the best!
UofU Patient
May 18, 2020
HUNTSMAN CANCER CENTER
dr Burke is a caring physician. She comes across as a very knowledgeable and very credible radiologist.
UofU Patient
May 11, 2020
HUNTSMAN CANCER CENTER
Overall I had a very positive experience at Huntsman!
UofU Patient
April 11, 2020
HUNTSMAN CANCER CENTER
Dr Burt is a wonderful doctor
UofU Patient
April 05, 2020
HUNTSMAN CANCER CENTER
Everyone that I saw explained everything very thoroughly and so I could understand.
UofU Patient
March 13, 2020
HUNTSMAN CANCER CENTER
Very little discussion this time, I guess because this was the second visit. I felt like I had more questions, but didnt really get a chance to ask them.
UofU Patient
March 12, 2020
SUGAR HOUSE HEALTH CENTER
Really enjoyed the conversation with Dr. Burt
UofU Patient
February 19, 2020
SUGAR HOUSE HEALTH CENTER
Dr. Burt and Suzanne have always been great!
UofU Patient
February 05, 2020
HUNTSMAN CANCER CENTER
Dr. Burt clearly explained the treatment, the expected outcome, and the risks for short and long term complications. From a medical standpoint, I have been well informed. She described options, and she told me I could change my mind. From a personal standpoint, the entire discussion was reassuring about the procedure and the team I will depend on.
UofU Patient
January 14, 2020
HUNTSMAN CANCER CENTER
very good experience
UofU Patient
December 27, 2019
HUNTSMAN CANCER CENTER
"BEST"
Lindsay Burt, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, Pediatric, and Breast teams.
Dr. Burt’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), accelerated partial breast irradiation (APBI), and high dose rate (HDR) and low dose rate (LDR) brachytherapy.
Dr. Burt earned a bachelor’s degree in Biology-Chemistry at Claremont McKenna College in Claremont, CA. She went on to complete medical school at the University of Utah School of Medicine and residency at the University of Utah Department of Radiation Oncology in Salt Lake City, UT. She is passionate about leadership, promoting education, and research. She served as the Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee while she was a resident and was a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) subcommittees and involved in many research projects. She is involved in clinical trials and has completed translational, clinical and database research.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Assistant Professor (Clinical) |
| Board Certification | American Board of Radiology (Radiation Oncology) |
Education History
| Certification | University of Utah Quality Improvement Certification, 2019 |
| Certification | University of Utah David Ecceles School of Business Health Science Leadership Program Certification, 2018 |
| Residency | University of Utah, Huntsman Cancer Hospital Radiation Oncology Resident, 2016 |
| Chief Resident | University of Utah, Huntsman Cancer Hospital Radiation Oncology Chief Resident, 2015 |
| Internship | Sacred Heart Medical Center Transitional Year Transitional Internship, 2012 |
| Professional Medical | University of Utah School of Medicine Medicine M.D., 2011 |
| Undergraduate | Claremont McKenna College Biology-Chemistry B.A., 2007 |
| Undergraduate | Boise State University, Honors College , 2004 |
| Undergraduate | Willamette University Chemical Engineering with Biomedical specialization , 2003 |
Selected Publications - Journal Articles
Journal Article
- Hsieh K, Housri N, Haffty B, Smith B, Burt LM (2021). Radiation oncologists' views on breast radiation therapy guidelines: Utilizing an online Q&A platform to assess current views on whole breast irradiation therapy. Clin Breast Cancer.
- Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol, 7, 173-182.
- Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL (2021). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. (Epub ahead of print) Breast Cancer Res Treat.
- Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt LM (2020). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. J Neurooncol, 151(2), 93-101.
- Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N (2020). Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clin Cancer Inform, 4, 794-798.
- Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman H (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial. J Neurooncol, 148(3), 577-585.
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92.
- Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2019). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42.
- Ager BJ, Christensen MT, Burt LM, Poppe MM (2019). The value of high-dose radiotherapy in intracranial ependymoma. Pediatr Blood Cancer, 66(6), e27697.
- Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol, 28(6), 377-384.
- Randa T, Lloyd S, Burt LM, Whisenant J, Garrido-Laguna I, Das P (2017). Pelvic Reirradiation for the Treatment of Locally Recurrent rectal Cancer. Current Colorectal Cancer Reports, 13(2), 175-182.
- Burt LM, Shrieve DC, Tward JD (2018). Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. Adv Radiat Oncol, 3(2), 170-180.
- Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast, 35, 122-129.
- Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017). Adjuvant radiotherapy for atypical meningiomas. J Neurosurg, 126(6), 1822-1828.
- Burt LM, Trifiletti DM, Nabavizadeh N, Katz LM, Morris ZS, Royce TJ (2017). Supply and Demand for Radiation Oncology in the United States: A Resident Perspective. 97(2), 225-227.
- Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK (2017). Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol, 2(2), 235-243.
- Mattes MD, Patel KR, Burt LM, Hirsch AE (2016). A Nationwide Medical Student Assessment of Oncology Education. J Cancer Educ, 31(4), 679-686.
- Verma V, Burt L, Gimotty PA, Ojerholm E (2016). Contemporary Trends in Radiation Oncology Resident Research. Int J Radiat Oncol Biol Phys, 96(4), 915-918.
- Burt LM, Poppe MM, Kokeny KE, Gaffney DK, Shrieve DC, Tward JD (2016). Comparison of Treatments for Breast Cancer Arising after Radiation Treatment for Hodgkin’s Lymphoma. J Radiat Oncol, 6(1), 65-72.
- Burt LM, Orlandi RR, Hunt JP, Buchmann LO, Grossmann KF, Monroe MM, Shrieve DC, Hitchcock Y (2016). Function Preservation and Optimal Outcomes – Definitive Chemoradiotherapy with Multi-phase Treatment Planning for Locally Advanced Sinonasal Cancer. J Radiat Oncol, 5(1), 47-54.
- Nabavizadeh N, Burt LM, Mancini BR, Morris ZS, Walker AJ, Miller SM, Bhavsar S, Mohindra P, Kim MB, Kharofa J (2016). Results of the 2013-2015 Association of Residents in Radiation Oncology Survey of Chief Residents in the United States. Int J Radiat Oncol Biol Phys, 94(2), 228-34.
- Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurg, 86, 210-9.
- Burt LM, Shrieve DC, Tward JD (2014). Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys, 88(1), 94-100.
- Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50.
Book Chapter
- Burt LM, Suneja G, Shrieve DC (2018). Pituitary Tumors. In Chang E, Brown P, Lo S, Sahgal A, Suh J (Eds.), Adult CNS Radiation Oncology (1st). Springer.